We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gut Segments Reunite in Model Culture System

By LabMedica International staff writers
Posted on 07 Sep 2015
An organ culture model system was created to evaluate physical manipulations aimed at enhancing the healing of gut segments in order to generate a single functional organ.

Investigators at the University of Manchester (United Kingdom) worked with embryonic mouse jejunum, which was isolated and cut into tubes two to three millimeters in length. More...
The paired segments separated by a small gap (about one millimeter) were placed in growth medium on semi-permeable supports. Each pair of segments was linked by a nylon suture threaded through their lumens.

Results published in the August 3, 2015, online edition of the Journal of Tissue Engineering and Regenerative Medicine revealed that after three days in organ culture fed by defined serum-free media, the rudiments differentiated to form tubes of smooth muscle surrounding a core of rudimentary villi. Of 34 such pairs, 74% had touching and well aligned proximate ends. Of these joined structures, 80% (59% of the total pairs) had a continuous lumen, as assessed by observing the trajectories of fluorescent dextrans injected into their distal ends. Fused organ pairs formed a single functional unit, as assessed by spontaneous contraction waves propagated along their lengths.

In some experiments the investigators added a growth factor called R-spondin 1 to the medium in an attempt to accelerate growth and make it more successful. Although this caused faster growth, it failed to establish the bridge in as uniform a way and fusion was less successful.

Senior author Dr. Adrian Woolf, professor of pediatric science at the University of Manchester, said, "The ability to study organs outside of the body is delivering new insights into how they work. In this case we have been able to study damaged intestines and instigate repairs which could lead to treatment in a number of conditions. In this study we managed to bridge a gap of less than one millimeter, but for this to be useful in conditions like short bowel syndrome we will need to promote growth across much larger distances. Having the ability to test different vitamins and hormones which promote growth opens up many new possibilities for future treatments."

Related Links:

University of Manchester



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The finger-prick blood test that measures plasma biomarkers associated with Alzheimer’s disease (Photo courtesy of 123RF)

Finger Prick Blood Test Shows Promise for Early Alzheimer’s Detection

Alzheimer’s disease remains difficult to diagnose early because definitive assessment often depends on costly imaging and invasive procedures that are not widely accessible. Current diagnostic pathways... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.